AtomVie Global Radiopharma und ITM schließen Liefervereinbarung über n.c.a. Lutetium-177
<p>HAMILTON, Ontario, und GARCHING, Deutschland, 20. November 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), ein Auftragsentwicklungs- und -herstellungsunternehmen (CDMO) für Radiopharmazeutika, und ITM Isotope Technologies Munich SE (ITM), ein führendes Biotechnologieunternehmen...</p>
Read original article ↗
Related Articles
AAEON targets semiconductors, robotics and defense beyond consumer AI inflation
Industrial PC maker AAEON Technology reported third-quarter 2026 revenue of NT$2.873 billion (US$87.46 million), up 24.6
POSCO 1% Foundation equips wounded vets with high-tech mobility gear
The POSCO 1% Foundation, a charity funded by POSCO Group employees, gave customized high-tech assistive devices to 26 wo
Nvidia builds physical AI ecosystem with Taiwan partners
The AI wave is moving beyond virtual cloud conversations into the era of physical AI, which interacts with the real worl
8 FPGA Standouts at electronica 2026
These FPGA exhibits at electronica highlighted advances in robotic control, embedded vision, development hardware, edge